Fund profile
Tickers
CNCR
Fund manager
Total assets
$11.34 mm
Liabilities
$7.21 k
Net assets
$11.33 mm
Number of holdings
87.00
CNCR stock data
87 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
IBRX ImmunityBio Inc | 283.19 k | 76.95 k shares | 2.50 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 260.07 k | 11.15 k shares | 2.29 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 258.63 k | 8.81 k shares | 2.28 | Common equity | Long | USA |
MGNX Macrogenics Inc | 244.04 k | 29.73 k shares | 2.15 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 237.84 k | 4.19 k shares | 2.10 | Common equity | Long | USA |
ACLX Arcellx Inc | 220.10 k | 4.19 k shares | 1.94 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 206.57 k | 48.26 k shares | 1.82 | Common equity | Long | UK |
NUVL Nuvalent Inc - Ordinary Shares | 191.27 k | 2.93 k shares | 1.69 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 190.60 k | 2.74 k shares | 1.68 | Common equity | Long | USA |
THRX Theseus Pharmaceuticals Inc | 182.61 k | 47.93 k shares | 1.61 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 181.56 k | 9.42 k shares | 1.60 | Common equity | Long | Hong Kong |
ZYME Zymeworks Inc. | 180.68 k | 20.37 k shares | 1.59 | Common equity | Long | USA |
RAIN Rain Oncology Inc | 176.93 k | 168.51 k shares | 1.56 | Common equity | Long | USA |
YMAB Y-Mabs Therapeutics Inc | 172.38 k | 27.76 k shares | 1.52 | Common equity | Long | USA |
AMAM Ambrx Biopharma Inc. | 171.15 k | 14.83 k shares | 1.51 | Common equity | Long | USA |
EXAI Exscientia Plc | 164.38 k | 26.95 k shares | 1.45 | Common equity | Long | UK |
MRSN Mersana Therapeutics Inc | 160.95 k | 97.55 k shares | 1.42 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 159.82 k | 5.26 k shares | 1.41 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 159.54 k | 26.28 k shares | 1.41 | Common equity | Long | USA |
FATE Fate Therapeutics Inc | 156.78 k | 62.96 k shares | 1.38 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 150.97 k | 7.27 k shares | 1.33 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc | 150.37 k | 74.07 k shares | 1.33 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 149.36 k | 4.75 k shares | 1.32 | Common equity | Long | USA |
VECT VectivBio Holding AG | 144.70 k | 8.51 k shares | 1.28 | Common equity | Long | Switzerland |
PRLD Prelude Therapeutics Inc | 144.18 k | 43.56 k shares | 1.27 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 141.79 k | 81.96 k shares | 1.25 | Common equity | Long | USA |
SGEN Seagen Inc. | 141.78 k | 665.00 shares | 1.25 | Common equity | Long | USA |
MRUS Merus N.V | 140.62 k | 5.68 k shares | 1.24 | Common equity | Long | Netherlands |
CRBU Caribou Biosciences Inc | 138.76 k | 23.64 k shares | 1.22 | Common equity | Long | USA |
EXEL Exelixis Inc | 138.52 k | 6.35 k shares | 1.22 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 138.40 k | 168.00 shares | 1.22 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 138.36 k | 2.62 k shares | 1.22 | Common equity | Long | UK |
BMEA Biomea Fusion Inc | 137.69 k | 9.14 k shares | 1.21 | Common equity | Long | USA |
INBX Inhibrx Inc | 137.60 k | 6.63 k shares | 1.21 | Common equity | Long | USA |
KURA Kura Oncology Inc | 135.44 k | 14.01 k shares | 1.20 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 132.81 k | 7.98 k shares | 1.17 | Common equity | Long | USA |
NUVB Nuvation Bio Inc - Ordinary Shares | 132.12 k | 106.55 k shares | 1.17 | Common equity | Long | USA |
MRK Merck & Co Inc | 132.10 k | 1.29 k shares | 1.17 | Common equity | Long | USA |
SDGR Schrodinger Inc | 130.39 k | 4.19 k shares | 1.15 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 130.16 k | 10.32 k shares | 1.15 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 126.99 k | 2.09 k shares | 1.12 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 126.85 k | 18.82 k shares | 1.12 | Common equity | Long | USA |
ARVN Arvinas Inc | 124.72 k | 5.68 k shares | 1.10 | Common equity | Long | USA |
TNGX Tango Therapeutics Inc | 123.71 k | 16.28 k shares | 1.09 | Common equity | Long | USA |
BNTX BioNTech SE | 123.10 k | 1.23 k shares | 1.09 | Common equity | Long | Germany |
XNCR Xencor Inc | 122.79 k | 6.70 k shares | 1.08 | Common equity | Long | USA |
JANX Janux Therapeutics Inc | 122.53 k | 14.04 k shares | 1.08 | Common equity | Long | USA |
GERN Geron Corp. | 120.96 k | 62.68 k shares | 1.07 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 118.05 k | 14.72 k shares | 1.04 | Common equity | Long | USA |
MorphoSys AG
|
117.85 k | 17.23 k shares | 1.04 | Common equity | Long | Germany |
RLAY Relay Therapeutics Inc | 116.93 k | 14.78 k shares | 1.03 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 115.89 k | 2.35 k shares | 1.02 | Common equity | Long | USA |
GMAB Genmab | 115.31 k | 3.65 k shares | 1.02 | Common equity | Long | Denmark |
DAWN Day One Biopharmaceuticals Inc | 115.23 k | 9.95 k shares | 1.02 | Common equity | Long | USA |
CGEM Cullinan Oncology Inc | 113.91 k | 13.91 k shares | 1.01 | Common equity | Long | USA |
IMRX Immuneering Corp - Ordinary Shares | 112.88 k | 17.21 k shares | 1.00 | Common equity | Long | USA |
IPHA Innate Pharma | 111.18 k | 46.33 k shares | 0.98 | Common equity | Long | France |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 110.72 k | 16.16 k shares | 0.98 | Common equity | Long | USA |
TYRA Tyra Biosciences Inc | 110.27 k | 9.42 k shares | 0.97 | Common equity | Long | USA |
VOR Vor Biopharma Inc | 109.98 k | 59.45 k shares | 0.97 | Common equity | Long | USA |
CMPX Compass Therapeutics Inc | 107.30 k | 65.03 k shares | 0.95 | Common equity | Long | USA |
ITOS ITeos Therapeutics Inc | 105.23 k | 11.24 k shares | 0.93 | Common equity | Long | USA |
PGEN Precigen Inc | 104.12 k | 92.96 k shares | 0.92 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 103.15 k | 7.10 k shares | 0.91 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 101.41 k | 6.73 k shares | 0.89 | Common equity | Long | USA |
IMTX Immatics N.V | 100.45 k | 11.36 k shares | 0.89 | Common equity | Long | Germany |
NRIX Nurix Therapeutics Inc | 97.24 k | 15.63 k shares | 0.86 | Common equity | Long | USA |
BLNK Blink Charging Co | 96.88 k | 8.60 k shares | 0.85 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 95.72 k | 6.65 k shares | 0.84 | Common equity | Long | UK |
ACET Adicet Bio Inc | 95.58 k | 81.00 k shares | 0.84 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 92.58 k | 71.77 k shares | 0.82 | Common equity | Long | USA |
STRO Sutro Biopharma Inc | 92.46 k | 35.43 k shares | 0.82 | Common equity | Long | USA |
ERAS Erasca Inc | 91.27 k | 53.69 k shares | 0.81 | Common equity | Long | USA |
FHTX Foghorn Therapeutics Inc | 90.43 k | 21.28 k shares | 0.80 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc | 88.15 k | 114.48 k shares | 0.78 | Common equity | Long | USA |
REPL Replimune Group Inc | 86.57 k | 7.74 k shares | 0.76 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 83.68 k | 35.61 k shares | 0.74 | Common equity | Long | USA |
AGEN Agenus Inc | 82.17 k | 105.74 k shares | 0.73 | Common equity | Long | USA |
NGM Ngm Biopharmaceuticals Inc | 78.97 k | 105.74 k shares | 0.70 | Common equity | Long | USA |
GNLX Genelux Corp | 72.90 k | 6.13 k shares | 0.64 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 71.45 k | 23.05 k shares | 0.63 | Common equity | Long | USA |
RPTX Repare Therapeutics Inc | 69.12 k | 13.42 k shares | 0.61 | Common equity | Long | Canada |
ZNTL Zentalis Pharmaceuticals Inc | 66.57 k | 5.92 k shares | 0.59 | Common equity | Long | USA |
TSVT 2seventy bio Inc | 62.59 k | 34.20 k shares | 0.55 | Common equity | Long | USA |
ACRV Acrivon Therapeutics Inc | 53.18 k | 13.13 k shares | 0.47 | Common equity | Long | USA |
Apollomics Inc
|
32.65 k | 34.55 k shares | 0.29 | Common equity | Long | USA |
First American Government Obligations Fund | 13.24 k | 13.24 k shares | 0.12 | Short-term investment vehicle | Long | USA |